Page last updated: 2024-08-25

rosiglitazone and Injuries, Radiation

rosiglitazone has been researched along with Injuries, Radiation in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, H; Feng, Z; Hu, L; Meng, Q; Zhang, H; Zhang, X	1

Other Studies

1 other study(ies) available for rosiglitazone and Injuries, Radiation

Article	Year
Rosiglitazone ameliorates radiation-induced intestinal inflammation in rats by inhibiting NLRP3 inflammasome and TNF-α production. Journal of radiation research, 2020, Nov-16, Volume: 61, Issue:6 Topics: Animals; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Hypoglycemic Agents; In Vitro Techniques; Inflammasomes; Inflammation; Interleukin-1beta; Intestines; Macrophages; Macrophages, Peritoneal; Male; NLR Family, Pyrin Domain-Containing 3 Protein; Radiation Injuries; Rats; Rats, Sprague-Dawley; Rosiglitazone; Tumor Necrosis Factor-alpha	2020

Article

Year

Rosiglitazone ameliorates radiation-induced intestinal inflammation in rats by inhibiting NLRP3 inflammasome and TNF-α production.

Journal of radiation research, 2020, Nov-16, Volume: 61, Issue:6

Topics: Animals; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Hypoglycemic Agents; In Vitro Techniques; Inflammasomes; Inflammation; Interleukin-1beta; Intestines; Macrophages; Macrophages, Peritoneal; Male; NLR Family, Pyrin Domain-Containing 3 Protein; Radiation Injuries; Rats; Rats, Sprague-Dawley; Rosiglitazone; Tumor Necrosis Factor-alpha

2020